Singapore, December 3, 2013 - Over 400 scientists worldwide will converge in Singapore for the 3rd Nano Today Conference which will be held at the Biopolis on December 9 to 11, 2013. Organized by Nano Today, a leading journal for nanoscience and nanotechnology, the Institute of Bioengineering and Nanotechnology (IBN) and Elsevier, the three-day conference will showcase the latest research advances in nanostructured materials and systems for diverse applications in areas such as biomedical, electronic, chemical and energy.
Chaired by Nano Today Editor-in-Chief and IBN Executive Director, Professor Jackie Y. Ying, this conference will feature 3 plenary lectures by Professor Younan Xia (Georgia Institute of Technology, USA), Professor Joseph M. DeSimone (University of North Carolina, USA) and Professor Mostafa A. El-Sayed (Georgia Institute of Technology, USA), invited talks by 25 distinguished scientists from internationally renowned institutions, as well as 17 contributed oral and over 220 poster presentations.
"Nanotechnology offers a new approach to tackling many problems, and the numerous research breakthroughs in recent years have demonstrated the potential of this rapidly evolving field. The Nano Today conference series aim to feature the latest advances and applications of nanotechnology. IBN is delighted to host the third conference in Singapore with Nano Today and Elsevier. We are honored to have a large number of leading experts as invited speakers for our conference, and the participation of researchers and students from 45 countries. We look forward to a stimulating and exciting meeting," said Professor Jackie Y. Ying.
"This is a particularly exciting time for research in all areas of nanoscience and nanotechnology, and particularly as these areas touch on materials science and engineering. Such is the growth in the number of nanomaterial-related articles we receive across all of our journals, and such is the demand from researchers to know where the science is going, that a conference such as this is both timely and uniquely placed to help the research community make sense of what is a dynamic and growing focus of research. I am very proud that Nano Today is sponsoring this successful conference as it makes its third appearance, and my thanks go to Jackie Ying and all of the IBN team for making this happen," said Deborah Logan, Publishing Director, Materials Science Journals, Elsevier.
The first Nano Today Conference was held in Singapore in 2009. Since then, the Nano Today Conference Series has established itself as a major forum for the international research community.
Nano Today is ranked the second most influential journal internationally in Nanoscience and Nanotechnology by Thomson Reuters (Journal Citation Reports®, June 2013). Since successfully transitioning from a magazine to a journal format in 2009 under Professor Ying's leadership, Nano Today has recorded major increases in Impact Factor from 5.929 in 2007 to 17.689 in 2012. This latest impact factor rating also placed the journal #4 out of 239 journals in Materials Science (Multidisciplinary), and #5 out of 152 journals in Chemistry (Multidisciplinary), consolidating its position as a leading journal that serves a broad readership. Nano Today is also the only Asia-based journal among the top 5 journals in each list.
At each Nano Today conference, one outstanding scientist is recognized for his/her distinguished accomplishments and contributions to the advancement of nanotechnology with the Nano Today Award. This year, the Nano Today 2013 Award will be presented to Professor Younan Xia for his pioneering research in the field of nanostructured materials.
To support the participation of young researchers, 12 PhD students and postdoctoral fellows from 9 countries have been selected to receive the Nano Today Student Travel Award. The award recipients will receive a travel grant, conference registration fee waiver and the opportunity to present their research findings at the conference.
Please refer to the appendix for the speakers' bios and talk abstracts. More information about the event and the speakers are available at http://www.
Details of Event
Event: 3rd Nano Today Conference
Date: December 9-10, 2013
Time: December 9, 8.30am to 6.00pm
December 10, 8.45am to 6.00pm
December 11, 8.45am to 5.30pm
Venue: Level 2, Matrix, Biopolis
30 Biopolis Street
Please email your particulars to Elena Tan at email@example.com by Friday, December 6, 2013.
For media queries and interview requests on the 3rd Nano Today Conference and IBN, please contact:
For media queries on Nano Today and Elsevier, please contact:
Phone: +44 1865 843 821
About the Institute of Bioengineering and Nanotechnology
Established in 2003, the Institute of Bioengineering and Nanotechnology (IBN) is spearheaded by its Executive Director, Professor Jackie Yi-Ru Ying, who was a Professor of Chemical Engineering at the Massachusetts Institute of Technology (1992‒2005). In 2008, Professor Ying was recognized as one of "One Hundred Engineers of the Modern Era" by the American Institute of Chemical Engineers for her groundbreaking work on nanostructured systems, nanoporous materials and host matrices for quantum dots and wires. Under her direction, IBN conducts research at the cutting-edge of bioengineering and nanotechnology. Its programs are geared towards linking multiple disciplines across engineering, science and medicine to produce research breakthroughs that will improve healthcare and our quality of life.
IBN's research activities are focused in the following areas:
- Nanomedicine, where functionalized polymers, hydrogels and biologics are developed as therapeutics and carriers for the controlled release and targeted delivery of therapeutics to diseased cells and organs.
- Cell and Tissue Engineering, where biomimicking materials, stem cell technology, microfluidic systems and bioimaging tools are combined to develop novel approaches to regenerative medicine and artificial organs.
- Biodevices and Diagnostics, which involve nanotechnology and microfabricated platforms for high-throughput biomarker and drug screening, automated biologics synthesis, and rapid disease diagnosis.
- Green Chemistry and Energy, which encompass the green synthesis of chemicals and pharmaceuticals, catalytic conversion of biomass, utilization of carbon dioxide, and new nanocomposite materials for energy applications.
For more information about IBN, please visit: http://www.
About Nano Today
Nano Today: An International Rapid Reviews Journal provides a peer-reviewed forum for the publication of authoritative review articles, rapid communications, news and opinions to shape and define the frontiers of nanoscience and nanotechnology through their multidisciplinary applications. Nano Today publishes six print issues per year covering all aspects of nanoscience and nanotechnology. The Nano Today journal is the second most influential journal internationally in Nanoscience and Nanotechnology with an impact factor of 17.689 (Thomson Reuters Journal Citation Reports®, June 2013).For more information, please log on to http://www.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group PLC is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.
About the Agency for Science, Technology and Research (A*STAR)
The Agency for Science, Technology and Research (A*STAR) is Singapore's lead public sector agency that fosters world-class scientific research and talent to drive economic growth and transform Singapore into a vibrant knowledge-based and innovation driven economy. In line with its mission-oriented mandate, A*STAR spearheads research and development in fields that are essential to growing Singapore's manufacturing sector and catalysing new growth industries. A*STAR supports these economic clusters by providing intellectual, human and industrial capital to its partners in industry.
A*STAR oversees 20 biomedical sciences and physical sciences and engineering research entities, located in Biopolis and Fusionopolis as well as their vicinity. These two R&D hubs, house a bustling and diverse community of local and international research scientists and engineers from A*STAR's research entities as well as a growing number of corporate laboratories.
For more information about A*STAR, please visit http://www.